Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report

An inflammatory myofibroblastic tumor (IMT) is an immunohistochemically diverse entity demonstrating neoplastic and nonneoplastic qualities. Although IMTs can arise in any area of the body, lesions arising in certain sites, namely, the nasal cavity, paranasal sinuses, and pterygopalatine fossa, demo...

Full description

Bibliographic Details
Main Authors: Chase C. Hansen, Colby Eisenbach, Carlos Torres, Suzanne Graham, Fred Hardwicke
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2015/953857
id doaj-c76cf928c57a498f972bd4ea56fffca2
record_format Article
spelling doaj-c76cf928c57a498f972bd4ea56fffca22020-11-24T23:02:07ZengHindawi LimitedCase Reports in Oncological Medicine2090-67062090-67142015-01-01201510.1155/2015/953857953857Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case ReportChase C. Hansen0Colby Eisenbach1Carlos Torres2Suzanne Graham3Fred Hardwicke4Department of Radiation Oncology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USADepartment of Radiation Oncology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USADepartment of Radiation Oncology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USADepartment of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USADepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USAAn inflammatory myofibroblastic tumor (IMT) is an immunohistochemically diverse entity demonstrating neoplastic and nonneoplastic qualities. Although IMTs can arise in any area of the body, lesions arising in certain sites, namely, the nasal cavity, paranasal sinuses, and pterygopalatine fossa, demonstrate a heightened neoplastic and invasive potential. Despite case specific complete tumor regression and disease remission in response to pharmacotherapeutics, a subset of IMTs remain resistant to all forms of therapy. We present such a case, a 34-year-old female patient, with a highly resistant, maxillary sinus IMT. Her refractory, ALK-1 negative IMT has not responded well to novel therapies reported in current literature. This case suggests the role of zonal expressivity within a single lesion as a probable mechanism for its highly resistant nature and should promote determination of each IMT’s cytogenetic profile to provide more effective targeted therapy. Paper includes a literature review of all maxillary sinus IMTs from 1985 to 2014 along with their immunohistochemical staining, treatments, and outcomes.http://dx.doi.org/10.1155/2015/953857
collection DOAJ
language English
format Article
sources DOAJ
author Chase C. Hansen
Colby Eisenbach
Carlos Torres
Suzanne Graham
Fred Hardwicke
spellingShingle Chase C. Hansen
Colby Eisenbach
Carlos Torres
Suzanne Graham
Fred Hardwicke
Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report
Case Reports in Oncological Medicine
author_facet Chase C. Hansen
Colby Eisenbach
Carlos Torres
Suzanne Graham
Fred Hardwicke
author_sort Chase C. Hansen
title Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report
title_short Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report
title_full Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report
title_fullStr Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report
title_full_unstemmed Maxillary Sinus Inflammatory Myofibroblastic Tumors: A Review and Case Report
title_sort maxillary sinus inflammatory myofibroblastic tumors: a review and case report
publisher Hindawi Limited
series Case Reports in Oncological Medicine
issn 2090-6706
2090-6714
publishDate 2015-01-01
description An inflammatory myofibroblastic tumor (IMT) is an immunohistochemically diverse entity demonstrating neoplastic and nonneoplastic qualities. Although IMTs can arise in any area of the body, lesions arising in certain sites, namely, the nasal cavity, paranasal sinuses, and pterygopalatine fossa, demonstrate a heightened neoplastic and invasive potential. Despite case specific complete tumor regression and disease remission in response to pharmacotherapeutics, a subset of IMTs remain resistant to all forms of therapy. We present such a case, a 34-year-old female patient, with a highly resistant, maxillary sinus IMT. Her refractory, ALK-1 negative IMT has not responded well to novel therapies reported in current literature. This case suggests the role of zonal expressivity within a single lesion as a probable mechanism for its highly resistant nature and should promote determination of each IMT’s cytogenetic profile to provide more effective targeted therapy. Paper includes a literature review of all maxillary sinus IMTs from 1985 to 2014 along with their immunohistochemical staining, treatments, and outcomes.
url http://dx.doi.org/10.1155/2015/953857
work_keys_str_mv AT chasechansen maxillarysinusinflammatorymyofibroblastictumorsareviewandcasereport
AT colbyeisenbach maxillarysinusinflammatorymyofibroblastictumorsareviewandcasereport
AT carlostorres maxillarysinusinflammatorymyofibroblastictumorsareviewandcasereport
AT suzannegraham maxillarysinusinflammatorymyofibroblastictumorsareviewandcasereport
AT fredhardwicke maxillarysinusinflammatorymyofibroblastictumorsareviewandcasereport
_version_ 1725637317524193280